STAGE IIB BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE IIB BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IIB BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail may shrink tough breast tumors before surgery
Disease control CompletedThis study tested a combination of three drugs (panitumumab, carboplatin, and paclitaxel) given before surgery to 43 women with a hard-to-treat type of breast cancer called triple-negative breast cancer. The goal was to see if this treatment could shrink tumors enough to reduce t…
Matched conditions: STAGE IIB BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study tested a combination of two chemotherapy drugs (cyclophosphamide and paclitaxel) plus a targeted therapy (trastuzumab) given after surgery to 20 patients with early-stage HER2-positive breast cancer. The goal was to see if this treatment could prevent the cancer from c…
Matched conditions: STAGE IIB BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New combo shrinks hard-to-treat breast tumors before surgery
Disease control CompletedThis study tested a combination of enzalutamide (a hormone blocker) and paclitaxel (chemotherapy) given before surgery to 24 people with a specific type of triple-negative breast cancer that has androgen receptors. The goal was to see if this treatment could shrink tumors enough …
Matched conditions: STAGE IIB BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Could adding two drugs before surgery boost breast cancer remission?
Disease control CompletedThis study tested whether adding carboplatin and/or bevacizumab to standard chemotherapy before surgery helps shrink tumors more effectively in people with a hard-to-treat type of breast cancer (hormone receptor-poor, HER2-negative). About 454 participants received weekly paclita…
Matched conditions: STAGE IIB BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 27, 2026 23:04 UTC
-
Smart bottles and video chats boost cancer pill taking
Knowledge-focused CompletedThis study tested whether using telehealth (video chats with doctors) and smart pill bottles can help breast cancer patients take their hormone-blocking pills more regularly. 305 people with early-stage breast cancer took part. The goal was to see if these tools improve how well …
Matched conditions: STAGE IIB BREAST CANCER AJCC V6 AND V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC